Total Payments
$751.67
2024 Payments
$52.04
Companies
7
Transactions
41
Medicare Patients
1,277
Medicare Billing
$240,187
Payment Breakdown by Category
Food & Beverage$751.67 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $751.67 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $377.63 | 19 | $0 (2022) |
| Horizon Pharma plc | $142.83 | 9 | $0 (2018) |
| IBSA Pharma Inc. | $112.50 | 6 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $43.44 | 2 | $0 (2021) |
| PFIZER INC. | $32.16 | 2 | $0 (2019) |
| Scilex Pharmaceuticals Inc. | $24.61 | 2 | $0 (2019) |
| Vertical Pharmaceuticals, LLC | $18.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.04 | 3 | IBSA Pharma Inc. ($52.04) |
| 2023 | $60.46 | 3 | IBSA Pharma Inc. ($60.46) |
| 2022 | $124.79 | 6 | Horizon Therapeutics plc ($124.79) |
| 2021 | $136.19 | 6 | Horizon Therapeutics plc ($92.75) |
| 2020 | $119.85 | 7 | Horizon Therapeutics plc ($119.85) |
| 2019 | $77.06 | 5 | Horizon Therapeutics plc ($40.24) |
| 2018 | $38.53 | 2 | PFIZER INC. ($19.95) |
| 2017 | $142.75 | 9 | Horizon Pharma plc ($124.25) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Endocrinology | ||||||
| 03/27/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Endocrinology | ||||||
| 12/13/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: non-opioid analgesic | ||||||
| 07/20/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: non-opioid analgesic | ||||||
| 04/15/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: non-opioid analgesic | ||||||
| 08/30/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: PENNSAID | ||||||
| 07/29/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: PENNSAID | ||||||
| 06/03/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: PENNSAID | ||||||
| 04/22/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: PENNSAID | ||||||
| 02/14/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: PENNSAID | ||||||
| 02/14/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: PENNSAID | ||||||
| 12/03/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: PENNSAID | ||||||
| 12/01/2021 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 10/08/2021 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: RAYOS | ||||||
| 09/29/2021 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Neurology | ||||||
| 05/14/2021 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: DUEXIS | ||||||
| 03/15/2021 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: RAYOS | ||||||
| 12/04/2020 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: RAYOS | ||||||
| 12/04/2020 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: RAYOS | ||||||
| 10/05/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: DUEXIS | ||||||
| 07/22/2020 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RAYOS | ||||||
| 06/29/2020 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: PENNSAID | ||||||
| 05/13/2020 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: PENNSAID | ||||||
| 02/20/2020 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: VIMOVO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 310 | 1,993 | $82,534 | $57,036 |
| 2022 | 13 | 375 | 2,306 | $99,353 | $70,473 |
| 2021 | 11 | 310 | 2,376 | $93,283 | $66,374 |
| 2020 | 12 | 282 | 1,467 | $61,082 | $46,303 |
Total Patients
1,277
Total Services
8,142
Medicare Billing
$240,187
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 41 | 555 | $19,670 | $15,105 | 76.8% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 43 | 585 | $19,966 | $11,562 | 57.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 31 | 77 | $9,070 | $6,591 | 72.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 104 | $8,006 | $5,916 | 73.9% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 40 | 547 | $7,773 | $4,513 | 58.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 25 | 27 | $5,659 | $4,385 | 77.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $3,289 | $2,333 | 70.9% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 14 | 14 | $2,173 | $1,704 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 23 | $2,613 | $1,599 | 61.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 13 | 13 | $1,927 | $1,456 | 75.6% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 14 | 14 | $1,778 | $1,394 | 78.4% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 13 | 13 | $609.18 | $477.62 | 78.4% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2022 | 42 | 645 | $22,966 | $17,768 | 77.4% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 45 | 657 | $23,055 | $13,532 | 58.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 37 | 84 | $10,324 | $8,159 | 79.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 35 | 38 | $8,285 | $6,553 | 79.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 99 | $7,889 | $6,009 | 76.2% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2022 | 41 | 638 | $9,349 | $5,465 | 58.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $4,906 | $3,613 | 73.7% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2022 | 19 | 19 | $2,971 | $2,347 | 79.0% |
| 92540 | Evaluation and testing for balance with recording | Office | 2022 | 20 | 20 | $2,635 | $2,025 | 76.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 24 | $2,770 | $1,850 | 66.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 14 | 14 | $2,181 | $1,602 | 73.5% |
| 92548 | Test for balance and posture | Office | 2022 | 18 | 18 | $1,051 | $783.65 | 74.6% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2022 | 20 | 20 | $971.20 | $766.86 | 79.0% |
About Dr. Imelda Cruz-Banting, M.D
Dr. Imelda Cruz-Banting, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760458137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imelda Cruz-Banting, M.D has received a total of $751.67 in payments from pharmaceutical and medical device companies, with $52.04 received in 2024. These payments were reported across 41 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($751.67).
As a Medicare-enrolled provider, Cruz-Banting has provided services to 1,277 Medicare beneficiaries, totaling 8,142 services with total Medicare billing of $240,187. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Bronx, NY
- Active Since 02/27/2006
- Last Updated 04/01/2014
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760458137
Products in Payments
- PENNSAID (Drug) $312.05
- RAYOS (Drug) $94.69
- LICART (Drug) $60.46
- DUEXIS (Drug) $59.70
- VIMOVO (Drug) $54.02
- Tirosint (Drug) $52.04
- DYSPORT (Drug) $43.44
- LYRICA (Drug) $32.16
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $24.61
- LORZONE (Drug) $18.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Bronx
Yuxi Chen, Md, MD
Physical Medicine & Rehabilitation — Payments: $14,301
Physical Medicine & Rehabilitation $14,301
Dr. Andrew Gitkind, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $7,290
Physical Medicine & Rehabilitation $7,290
Dr. Adnan Qureshi, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $5,966
Physical Medicine & Rehabilitation $5,966
Dr. Karen Morice, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,326
Physical Medicine & Rehabilitation $2,326
Naglaa Hussein, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,186
Physical Medicine & Rehabilitation $2,186
Dr. Timur Hanan, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,764
Physical Medicine & Rehabilitation $1,764